Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.00 (0.00%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £18.38m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Directorate Change

28 Jan 2025 07:00

RNS Number : 8562U
Inspiration Healthcare Group PLC
28 January 2025
 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Board changes

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the retirement of Bob Beveridge, Non-Executive Director ("NED") who is stepping down after nine years in line with best practice. Bob will be replaced as NED and Chair of the Audit Committee by Richard Jones. The Board wish to thank Bob for his years of service and commitment to Inspiration Healthcare during his tenure and are delighted to be able to appoint Richard to the role. Both changes will come into effect from 31 January 2025.

 

Richard is a seasoned healthcare and life sciences professional with extensive experience as a board member of publicly listed companies. He has spent more than 20 years serving in both independent NED and Executive Director roles and has acted as a key adviser across a diverse range of public and private companies in the life sciences space. He has expertise across a wide spectrum of Board issues and has worked extensively outside the UK PLC market having completed a US reverse merger as CFO for a UK biotech company in 2019.

 

Currently he is a Senior Independent Director and Audit Committee Chair of Alliance Pharma PLC, an AIM listed international consumer healthcare company where he is closely involved in all aspects of the business. Formerly, he was Chief Financial Officer ("CFO") and Company Secretary of the UK and Ireland's leading supplier of tele-radiology services, Medica Group Ltd. His CFO and Board experience also includes Mereo Biopharma PLC and Shield Therapeutics PLC.

 

Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are delighted to welcome Richard on board, and we are excited to be able to tap into his extensive capital markets experience, as well as his in-depth knowledge of the US market where we continue to grow our presence.

 

"On behalf of the Board, I would like to thank Bob for his dedication and commitment to Inspiration Healthcare over almost a decade. We will be sad to see him go, and we wish him all the very best for his future plans."

 

Bob Beveridge, outgoing Non-Executive Director said: "I have thoroughly enjoyed my time with the Inspiration Healthcare team over the years. I believe they are at a key transitional phase, and I know they will be a great success. I wish them well for a bright future."

 

Richard Jones, incoming Non-Executive Director added: "I am looking forward to joining the Board of Inspiration Healthcare and sharing my PLC and life sciences industry expertise with the team."

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Richard Crispin Morgan Jones (aged 58 years) holds / has held the following directorships/partnerships in the last five years:

 

Current directorships / partnerships

Previous directorships / partnerships in last 5 years

Alliance Pharma plc

Global Diagnostics Ireland Ltd

C4X Discovery Holdings Limited

Global Retinopathy Screening Ltd

Hampshire Topco Limited

JCA Seminars Limited

Hero Acquisitions Limited

Medica Australia Pty Ltd

HSS Hire Group plc

Medica Group Limited

HSS Hire Service Finance Limited

Medica IT Services Limited

RCMJ Consultancy Ltd

Medica Reporting Finance Limited

Medica Reporting Limited

Medica Reporting Services Limited

Medica US Inc

Med-IDX Pty Ltd

Med-IDX UK Limited

Mereo Biopharma 1 Limited

Mereo Biopharma 2 Limited

Mereo Biopharma 3 Limited

Mereo Biopharma 4 Limited

Mereo Biopharma Group plc

Mereo BioPharma Ireland Limited

Mereo MereoCo Inc

Mereo US Holdings Inc

Moonlight Bidco Limited

Moonlight Midco 1 Limited

Moonlight Midco 2 Limited

Moonlight Topco Limited

 

Richard Crispin Morgan Jones does not hold any ordinary shares in the capital of the Company. There are no further disclosures to be made in accordance with AIM Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

 

For further information, please contact:

 

Inspiration Healthcare Group plc

Tel: +44 (0)330 175 0000

Roy Davis, Executive Chair

Alan Olby, Chief Financial Officer

Panmure Liberum (Nominated Adviser & Broker)

Tel: +44 (0)20 3100 2000

Richard Lindley

Will King

 

Walbrook PR Ltd (Media and Investor Relations)

Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com

Anna Dunphy

Mob: +44 (0) 7876 741 001

Louis Ashe-Jepson

Mob: +44 (0) 7747 515 393

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDBLUDDGUR
Date   Source Headline
24th May 20237:00 amRNSAppointment of Nominated Adviser and Broker
17th May 20237:00 amRNSMello investor conference
4th May 20237:00 amRNSInvestor Day
3rd May 20237:00 amRNSFinal Results
6th Apr 20235:53 pmRNSGrant of Options
3rd Apr 20235:53 pmRNSGrant of Options
31st Mar 20236:27 pmRNSExercise of Options & Issue of Equity
23rd Mar 20237:00 amRNSLaunch of range extension of neonatal ventilators
1st Mar 20237:00 amRNSChange of Website
17th Feb 20232:05 pmRNSTR1 Notification
16th Feb 20237:00 amRNSTrading Update
9th Dec 20222:27 pmRNSTR1 Notification
8th Dec 20221:10 pmRNSTR1 Notification
5th Dec 20227:00 amRNSBoard Changes
30th Nov 202210:28 amRNSDirector / PDMR Dealing
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSUpdate on Trading
9th Nov 20227:00 amRNSUkraine Order
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
4th Oct 20222:05 pmRNSSecond Price Monitoring Extn
4th Oct 20222:00 pmRNSPrice Monitoring Extension
4th Oct 202211:05 amRNSSecond Price Monitoring Extn
4th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSInterim Results
21st Sep 20227:00 amRNSSignificant Japanese Order
1st Sep 20227:00 amRNSResults date and Investor events
15th Aug 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSCapital Markets Day
30th Jun 202212:58 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement
10th Jun 20221:00 pmRNSExercise of options and Total Voting Rights
7th Jun 20227:00 amRNS£1.3 million Iraq Order
6th Jun 20227:00 amRNSAnnual Report 2022 and Notice of AGM
24th May 20227:00 amRNSTR1 Notification
20th May 20223:09 pmRNSTR1 Notification
19th May 20227:00 amRNSMello Investor Conference
4th May 20227:00 amRNSFinal Results
25th Apr 20227:05 amRNSInvestor Presentation
8th Apr 20222:21 pmRNSGrant of Options
1st Apr 20227:00 amRNSLaunch of test to avoid hearing loss in neonates
17th Feb 20227:00 amRNSPost Period Trading Update and Notice of Results
14th Feb 20227:00 amRNS$1.37 million Egyptian Order
1st Feb 20229:00 amRNSCenkos Virtual Growth and Innovation Forum
9th Dec 20214:15 pmRNSTR1 Notification
9th Dec 20214:15 pmRNSTR1 Notification
2nd Dec 20217:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.